No retraction, correction or concern found when last checked on Oct 27, 2026.
FMRP promotes RNA localization to neuronal projections through interactions between its RGG domain and G-quadruplex RNA sequences
Raeann Goering, Laura I Hudish, Bryan B Guzman and 5 more
eLife · 2020 · CC BY
Abstract
The sorting of RNA molecules to subcellular locations facilitates the activity of spatially restricted processes. We have analyzed subcellular transcriptomes of FMRP-null mouse neuronal cells to identify transcripts that depend on FMRP for efficient transport to neurites. We found that these transcripts contain an enrichment of G-quadruplex sequences in their 3′ UTRs, suggesting that FMRP recognizes them to promote RNA localization. We observed similar results in neurons derived from Fragile X Syndrome patients. We identified the RGG domain of FMRP as important for binding G-quadruplexes and the transport of G-quadruplex-containing transcripts. Finally, we found that the translation and localization targets of FMRP were distinct and that an FMRP mutant that is unable to bind ribosomes still promoted localization of G-quadruplex-containing messages. This suggests that these two regulatory modes of FMRP may be functionally separated. These results provide a framework for the elucidation of similar mechanisms governed by other RNA-binding proteins.
Full text
From PubMed Central, U.S. National Library of Medicine, as current on Oct 27, 2026. Paragraph numbers are ours, so an answer can point at one.
Introduction
Essentially all eukaryotic cells contain subcellular regions that are associated with specific functions. The identity and activity of these regions are in large part defined by the proteins contained within them. Cells require an efficient sorting process to get proteins required for function to their correct location. For many genes, this fundamental problem is solved by transporting the RNA molecule encoding the protein, rather than the protein itself, to the desired location. The transcript is then translated on-site to immediately produce a correctly localized protein.
RNA localization has been studied extensively in diverse systems. Thousands of transcripts are asymmetrically distributed within cells and therefore subject to localization regulation. However, precise molecular mechanisms that govern how transcripts are transported have been worked out in detail for only a small subset of heavily studied localized RNAs. In these RNAs, sequences that mark transcripts for transport, sometimes termed ‘zipcodes’, are often found in 3′ UTRs. Zipcode sequences are then bound by RNA-binding proteins (RBPs) that mediate RNA transport. The zipcode/RBP pairs that are known were often identified through careful but laborious reporter experiments that involve systematic deletions or mutations that inactivate putative regulatory elements.
A large disparity persists, though, between the number of RNAs that are targets of localization regulation and the number of known localization regulatory elements within those RNAs. High-throughput experiments that probe the localization of thousands of transcripts at once may be able to help bridge this gap. By providing many examples of transcripts whose localization is regulated by a given RBP, commonalities among those transcripts can shed light on general rules that define sequence features that regulate RNA localization as well as the RBP that binds them.
FMRP is an RBP that is highly expressed in the brain and has long been known to be the protein behind Fragile X syndrome (FXS). Loss of expression of the FMR1 gene in humans is associated with intellectual disabilities and occurs in approximately 1 in 5000 males. FMRP-null mice display similar phenotypes. FMRP has been shown to regulate RNA metabolism at the level of translational repression and RNA localization. The relative contribution of these activities to observed phenotypes is generally unclear. Although genome-wide studies probing the translation repression activity of FMRP have been performed, much less is known about the RNAs that depend on FMRP for efficient localization to neuronal projections. FMRP has been implicated in the transport of a handful of RNAs, but there is no general understanding of the identity of transcripts whose localization is regulated by FMRP.
How FMRP recognizes and binds its functional targets is also not well understood. Several studies have reported transcript and RNA motif targets for FMRP in vitro and in vivo, yet considerable disagreement among these studies remains about the identity of RNA sequences that interact with FMRP with high-affinity. RNA G-quadruplex sequences have been repeatedly identified as binding targets of FMRP, and studies that have looked at commonalities between published datasets have found enrichments for WGGA sequences consistent with G-quadruplex formation. However, other studies have found that FMRP binds completely different short RNA motifs while still others seem to show that FMRP displays almost no sequence specificity at all and instead binds all along the coding sequence of its target transcripts. Whether or not these potentially different modes of binding are related to the different functions of FMRP is again unknown.
Identification of transcripts that depend upon FMRP for efficient neuronal transport
We and others have previously used subcellular fractionation followed by high-throughput sequencing to quantify transcripts in the soma and neurites of neuronal cells. In these experiments, neuronal cells are plated on porous membranes (Figure 1A). The pores of these membranes are big enough to allow neurite growth through them but small enough to restrict soma growth to the top of the membrane. This allows the cells to be mechanically fractionated into soma and neurite fractions. RNA can then be isolated from both fractions and analyzed by high-throughput sequencing.
Given the utility of this technique, we then set out to define transcripts whose efficient localization to neurites depended on FMRP. Using CRISPR/Cas9, we created an FMRP-null CAD mouse neuronal cell line. CAD cells are derived from a mouse brain tumor and can be induced by serum starvation to display features of neuronal differentiation, including cell cycle downregulation, expression of neuronal markers, and the appearance of neuronal morphologies. The CAD FMRP knockout line was found to have a single basepair deletion in all alleles of Fmr1 (Figure 1—figure supplement 1) that caused a frameshift and a premature termination codon two codons downstream of the gRNA cut site. The premature termination codon was upstream of all identified RNA-binding domains in FMRP. The knockout cells displayed no detectable FMRP expression by immunoblotting, even when probed with a polyclonal FMRP antibody (Figure 1B).
We then fractionated wildtype and FMRP knockout CAD cells into soma and neurite fractions in triplicate. To monitor the efficiency of the fractionation, we assayed the expression of beta-actin, which should be present in all fractions, and histone H3, which, being nuclear, should be restricted to the soma (Figure 1C). RNA was isolated from each fractionation and profiled by high-throughput sequencing.
The expression of Fmr1 RNA was downregulated in FMRP knockout samples, as would be expected since the Cas9-induced lesion likely made the RNA a target of nonsense-mediated decay (Figure 1—figure supplement 2). Principal component analysis of gene expression values showed that replicates clustered together and samples were separated along the first two principal components by compartment and genotype, respectively (Figure 1—figure supplements 3 and 4). To quantify RNA localization, we defined a metric termed localization ratio (LR) as the log2 of a gene’s abundance in the neurite fraction divided by its abundance in the soma fraction. Positive LR values are therefore associated with neurite localization, and higher LR values are associated with stronger neurite localization.
Previous literature has demonstrated that transcripts encoding ribosomal proteins and components of the electron transport chain are strongly enriched in neurites. We therefore sought to assay the efficiency of our fractionation and RNA isolation by looking at the LR values of these genes. Reassuringly, we found that, in all samples, mRNAs encoding these proteins were strongly neurite-enriched (Figure 1—figure supplement 5).
To further monitor the quality of our fractionations and RNA samples, we compared data produced by these fractionations to data produced by similar neuronal subcellular transcriptomic experiments that had been previously published. In total, we calculated LR values for all expressed genes from 65 samples spanning two species, four laboratories, and nine neuronal cell types (;;;; Figure 1—figure supplement 6). We found that our LR values correlated well with LR values from other studies (R ~ 0.6 to 0.8) and that all 65 samples were significantly more similar to each other than would be expected by chance (Figure 1—figure supplement 7), giving us confidence that our subcellular sequencing data was comparable with previously published datasets. Furthermore, we found that transcripts encoding ribosomal proteins (Figure 1—figure supplement 8) and components of the electron transport chain (Figure 1—figure supplement 9) were neurite-enriched in a large majority of samples, confirming their status as markers of neurite RNA.
To identify genes whose transcripts depend on FMRP for efficient transport to neurites, we compared the LR values of genes between the wildtype and knockout samples using the R package Xtail. Xtail is designed to analyze ribosome profiling data to identify genes whose translational efficiency changes across conditions. However, since both translational efficiency and LR are ratios of gene expression values, we reasoned that Xtail would be a good tool to identify genes whose LR value changes across samples. Using Xtail and a false discovery rate cutoff of 0.01, we identified 86 genes whose transcripts displayed impaired neurite localization, and thus decreased LR values, in the FMR1 knockout (Figure 1D, Figure 1—figure supplement 10, Supplementary file 1a). We defined these genes as FMRP localization targets.
Gene ontology analysis of these targets revealed that they were enriched for genes that regulate vesicle transport in neurons (Figure 1—figure supplement 11). In particular, mRNAs encoding several kinesins were less localized in the FMRP knockout. Interestingly, mRNAs encoding kinesins have been recently identified as both bound and transported by FMRP in glial cells.
Because LR is a ratio of neurite to soma gene expression values, in principle, a decrease in LR could be due to either a decrease in neurite expression or an increase in soma expression. To investigate this further, we compared the expression of the mislocalized genes in the soma and neurite compartments separately. We found that while the expression of FMRP localization targets did not change in the soma between the wildtype and FMRP knockout samples, their expression in the neurites of FMRP knockout cells was significantly reduced (Figure 1E). Because the soma contains the vast majority of cellular RNA, this indicates that the overall expression and processing of the localization targets is not impaired yet their ability to be trafficked to neurites is reduced. These findings suggest that these genes are in fact misregulated at the level of RNA localization.
FMRP localization targets have significant enrichments of G-quadruplex sequences in their 3′ UTRs
After identifying functional RNA localization targets of FMRP, we then looked for commonalities among them that can give insight into how FMRP recognizes and binds them. If FMRP were directly regulating the localization of these targets, we would expect that FMRP directly binds them. To test this, we analyzed data from three previously published FMRP CLIP-seq datasets. Given the lack of consensus between multiple published FMRP binding datasets, we defined transcripts bound by FMRP as those that appeared in all three CLIP-seq datasets. FMRP localization targets were approximately 4-fold more likely to be directly bound by FMRP than expected by chance (Figure 2A).
We then performed the converse analysis to ask whether FMRP CLIP-seq targets were preferentially mislocalized in FMRP knockout cells. We found that the localization of FMRP CLIP-seq targets was significantly more sensitive to FMRP loss than CLIP-seq nontargets (Figure 2B).
To rigorously test the links between these three published CLIP-seq datasets and our FMRP localization targets, we then repeated these analyses using the FMRP CLIP-seq targets defined in each dataset individually instead of taking the overlap between them. For each CLIP-seq dataset, we found that our FMRP localization targets were enriched for FMRP binding (Figure 2—figure supplements 1, 3 and 5) and that FMRP-bound RNAs were significantly more likely to be mislocalized in FMRP knockout cells (Figure 2—figure supplements 2, 4 and 6). From these analyses, we conclude that FMRP is likely directly regulating the localization of these functional RNA localization targets.
We then reasoned that sequences that were enriched in FMRP localization targets relative to nontargets could represent preferred binding sites for FMRP. Because the majority of RNA sequence elements that regulate localization identified to date reside in 3′ UTRs, we compared the abundance of all 6mers in the 3′ UTRs of FMRP localization targets and nontargets. We observed a strong enrichment for the RNA sequence ‘GGA’ in the 3′ UTR of FMRP localization targets (Figure 2C). GGA had previously been identified from an FMRP CLIP-seq dataset as a preferred FMRP binding motif, giving us further confidence that our identified localization targets were directly bound and regulated by FMRP.
Tandem repeats of GGA sequences are known to have the ability to fold into G-quadruplex sequences. G-quadruplexes are four-stranded nucleic acid structures in which guanosine residues interact with each other across the strands. Given that G-quadruplex structures have been shown to be specifically bound by FMRP in vitro,, we then asked if G-quadruplex sequences were enriched in FMRP localization target sequences. To do so, we employed two computational methods to predict G-quadruplex sequences from RNA sequences. Using a regular expression we searched for four repeated WGGA sequences separated by 0–7 nucleotide linkers where W represents either adenosine or uracil. We also used the RNA secondary structure prediction software RNAfold. Both methods agreed that the 3′ UTRs of FMRP localization targets contained significantly more G-quadruplex sequences than nontargets (Figure 2D,E).
We then complemented these computational predictions of G-quadruplex sequences with previously published experimentally defined G-quadruplex sequences. These were identified by quantifying reverse transcriptase stop sites in the presence of either potassium or lithium. Because potassium stabilizes G-quadruplexes and lithium destabilizes them, stop sites that display differential abundance between the two conditions are likely due to G-quadruplexes. These experimentally defined G-quadruplexes displayed many expected properties, including a large enrichment for guanosine nucleotides (Figure 2—figure supplement 7), highly stable predicted secondary structures (Figure 2—figure supplement 8), and a strong enrichment for predicted G-quadruplexes using both the regular expression and RNAfold methods (Figure 2—figure supplements 9 and 10). The agreement between the computational and experimental approaches to G-quadruplex identification gave us confidence in the ability of both techniques. As with the computational predictions, we observed a significant enrichment of experimentally defined G-quadruplexes in the 3′ UTRs of FMRP localization targets (Figure 2F).
We then asked what other transcript features were associated with FMRP localization targets. We observed that FMRP localization targets had much longer open reading frames and 3′ UTRs than expected (Figure 2G), consistent with previous reports that 3′ UTR extensions and alternative 3′ UTRs can regulate RNA localization in neurons. We observed no relationship between the overall abundance of a transcript and whether or not it was an FMRP localization target. The enrichment of G-quadruplexes in FMRP localization targets was restricted to their 3′ UTRs as we did not observe a significant relationship between CDS or 5′ UTR G-quadruplex density and localization regulation by FMRP (Figure 2G).
G-quadruplexes are not positionally conserved but tend to be present in orthologous genes
The enrichment of G-quadruplex sequences in FMRP localization targets and the enrichment of those targets in FMRP CLIP-seq datasets suggested that the G-quadruplex sequences may be functional. If they were functional, we might expect them to be conserved. To test the conservation of G-quadruplex sequences, we compared the conservation of 3′ UTR guanosine residues predicted by RNAfold to participate in quadruplex interactions to those not predicted to be in quadruplexes. Surprisingly, we found that guanosines in quadruplexes were less conserved than those not in quadruplexes, and those in FMRP localization targets were less conserved than those in nontargets (Figure 2H). However, this analysis relies on elements being positionally conserved such that they can be aligned across genomes. Elements within UTRs do not have to be positionally conserved, only present, to be functional.
To assess this, we calculated G-quadruplex densities in the 3′ UTRs of the human orthologs of the FMRP localization targets and nontargets. We observed a significant enrichment of G-quadruplexes in the human orthologs of the FMRP localization targets, arguing that their function may be conserved across species (Figure 2I,J).
Mislocalized transcripts in FXS patient-derived neurons are enriched for G-quadruplex sequences
To more directly test the localization regulatory activity of FMRP in human cells, we created induced pluripotent stem (iPS) cell lines from FXS and unaffected patient samples. We differentiated these cells over the course of 20 days into motor neurons (;;;; Figure 3—figure supplement 1). We then plated these cells on porous membranes and performed the same subcellular fractionation and sequencing experiment that was performed on the CAD cell samples using four technical replicates.
As expected, the FXS neurons displayed a large decrease in both FMR1 RNA and FMRP protein (Figure 3A,B). We assayed the efficiency of the fractionation as before by immunoblotting (Figure 3—figure supplement 2) and looking for the enrichment of mRNAs encoding ribosomal proteins and components of the electron transport chain in the neurite fraction (Figure 3—figure supplement 3) and found that both performed as expected. Further, LR values obtained from the iPS neurons correlated well (R ~ 0.6 to 0.8) with those obtained from previously published neuronal subcellular sequencing datasets and with the CAD cell fractionation in Figure 1 (;;;;; Figure 1—figure supplement 6), indicating that the fractionation was efficient.
PCA analysis of gene expression values showed a separation of samples by compartment and genotype along the first two principal components (Figure 3—figure supplement 4). We first looked at the localization of the human orthologs of the FMRP localization targets that were identified in the mouse CAD system. Strikingly, the human orthologs of the mouse FMRP localization targets were significantly less neurite-localized in FXS neurons than in unaffected neurons, indicating that the functional localization targets of FMRP were broadly conserved across species (mouse and human) and experimental systems (neuronal cell line and iPS-derived neurons) (Figure 3C). Overall, we observed a modest (R = 0.21) but highly significant (p=1e-37) correlation between the mislocalization of genes in the CAD knockout system and the mislocalization of their human orthologs in the FXS iPS system (Figure 3—figure supplement 5, Supplementary file 1b).
We then defined genes whose localization differed between the FXS and unaffected samples. After quantifying the localization of genes in each sample, we found that very few genes met a reasonable FDR cutoff for mislocalization. This is perhaps due to the inherent variability in the differentiation of iPS cells into motor neurons from prep to prep or the difference in genetic background of the iPS lines adding noise to gene expression measurements (Figure 3—figure supplement 4). To define mislocalized genes, we therefore used a log2 fold change cutoff of 0.25 to define genes whose neurite-localization decreased in FXS (FMRP targets) or increased in FXS (FMRP nontargets) (Figure 3—figure supplement 6). We found that FMRP targets were significantly more likely to be directly bound by FMRP in cells as determined by CLIP than FMRP nontargets (Figure 3D;;; ). We also found that FMRP targets had significantly higher densities of G-quadruplexes in their 3′ UTRs than FMRP nontargets, suggesting that this mode of localization target recognition may be conserved between mice and humans (Figure 3E,F).
The RGG domain of FMRP specifically recognizes G-quadruplex sequences
Given our findings that FMRP localization targets were enriched for G-quadruplex sequences, we next sought to determine if FMRP directly interacted with G-quadruplex RNAs over other RNAs in vitro. To this end, we performed RNA Bind-n-Seq (RBNS), a quantitative and unbiased method that defines the specificity of a given RBP or RNA binding domain by incubating purified protein with a diverse pool of 1011 random RNA sequences. In this technique, the input RNA pool and protein-associated RNA are sequenced using high-throughput sequencing. RNA sequences that mediate protein binding are identified as those enriched in the protein-bound RNA relative to the input pool (Figure 4A). Importantly, this assay uses a single round of RNA selection and uncovers a continuous range of RBP specificity.
We set out to determine which domains within FMRP, if any, contained the ability to specifically interact with G-quadruplex sequences. FMRP contains two domain types that are known to bind RNA, a pair of KH domains and a single RGG domain (Figure 4A). We purified recombinant fragments of mouse FMRP that included either the KH domains or the RGG domain (Figure 4B). We then performed RBNS with a pool of random 40mers in the presence of either potassium, which promotes G-quadruplex folding, or lithium, which inhibits G-quadruplex folding. For each condition, we sequenced approximately 10 million RNA sequences in from both the input and protein-associated RNA pools. G-quadruplex RNA sequences, defined either as matches to specific motifs or through RNA folding predictions, were approximately 10-fold enriched in the RGG-associated RNA compared to the input pool (Figure 4C,D). Furthermore, the addition of lithium drastically reduced this enrichment of G-quadruplex sequences, indicating that the G-quadruplexes must be folded in order to interact with the RGG domain in vitro, as has been previously observed.
Using fluorescence polarization assays, we found that the RGG domain interacted with a G-quadruplex RNA in the presence of potassium with a high affinity (Kd ~30 nM). This value is comparable to previous estimates of the affinity. Repeating the assay in the presence of lithium showed reduced binding between the RGG domain and G-quadruplex RNA (Figure 4—figure supplement 1).
The KH domains of FMRP did not specifically interact with G-quadruplex sequences (Figure 4C,D), and we were unable to uncover any strong sequence specificity in the KH-bound RNA nor derive the affinity of the KH domain for any RNA. These data suggest that FMRP binds its RNA localization targets through interactions between its RGG domain and target transcripts.
The RGG domain of FMRP as well as a G-quadruplex sequence in target mRNAs are both required for efficient localization of RNAs
To investigate a functional relationship between the RGG domain of FMRP and G-quadruplex sequences within 3′ UTRs of localized mRNAs, we used single molecule FISH (smFISH) to monitor the localization of a reporter transcript in CAD cells that contained either no FMRP, full length FMRP, or a truncation of FMRP lacking the RGG domain. These cells were made by rescuing an FMRP knockout line with GFP, FMRP, or FMRPΔRGG, respectively (Figure 5A). The reporter transcript contained the coding sequence of Firefly luciferase followed by the 3′ UTR of the Nol3 gene (Nol3 3′ UTR). This UTR was chosen because we observed in our sequencing data that Nol3 was mislocalized in FMRP knockout CAD cells (LR log2 fold change = −0.9, p=3e-14). In separate experiments, we also monitored the localization of a version of the reporter transcript in which the only RNAfold-predicted G-quadruplex sequence had been removed (Nol3-G4 3′ UTR). The smFISH probes used to visualize the two reporters were identical and targeted the coding sequence of the transcript (Figure 5A).
Both the FMR1 rescue constructs and the reporter transcripts were integrated into the genome of the CAD cells using Cre-lox recombination into a single genomic site. Using this strategy, cell pools were virtually homogeneous for integration of the rescue constructs, and the expression of both the rescue constructs and the reporter transcripts were controllable with doxycyline. Protein levels were assayed via western blot with or without doxycycline induction to confirm expression of rescue constructs. We found that the expression level of FMRP in the rescued cells was similar to the expression of FMRP in wildtype cells (Figure 5B). We then monitored the efficiency of reporter transcript localization to neurites by smFISH and quantified the results using FISH-quant. We observed that the reporter transcript that contained a G-quadruplex sequence in its 3′ UTR was efficiently localized to neurites, but only in cells expressing full length FMRP (FMRP, Nol3 3′ UTR), and not in cells either completely lacking FMRP (GFP, Nol3 3′ UTR) or in cells expressing only a truncated form of FMRP (ΔRGG, Nol3 3′ UTR) (Figure 5C,D; Figure 5—figure supplement 1). Removal of the G-quadruplex sequence (Nol3-G4 3′ UTR) resulted in less efficient transcript localization regardless of the FMRP status of the cell (Figure 5C,D; Figure 5—figure supplement 1). These results are consistent with both the RGG domain of FMRP and a G-quadruplex sequence within the target transcript being required for efficient localization to neurites.
This observed defect in the transport of G-quadruplex-containing transcripts in the absence of the RGG domain of FMRP could be explained by two potential possibilities. It could be that the ΔRGG truncation was unable to bind the transcript in cells, or, alternatively, it could be that the ΔRGG truncation was unable to be transported to neurites. To distinguish between these possibilities, we tested the abilities of the ΔRGG truncation and the full length protein to bind the reporter transcripts in cells using CLIP-qPCR and assayed their ability to be transported to neurites using immunofluorescence.
To assay RNA binding ability, cells coexpressed one of the Firefly luciferase reporters, either containing or lacking a G-quadruplex (Figure 5A), and Renilla luciferase from a bidirectional promoter. RBPs were crosslinked to their bound RNAs using UV irradiation, and the rescuing FMRP construct was immunoprecipitated. By comparing the amounts of Firefly and Renilla luciferase transcripts in the input and immunoprecipitated samples using qPCR, relative levels of FMRP/Firefly RNA interaction in cells were determined. We found that the ΔRGG truncation showed significantly reduced interaction with the G-quadruplex-containing Firefly reporter compared to full length FMRP (Figure 5E, Figure 5—figure supplement 2). When we repeated the experiment using the Firefly reporter lacking the G-quadruplex, both full length FMRP and the ΔRGG truncation showed reduced, but importantly, equal, ability to bind the transcript (Figure 5E). These results are consistent with the in vitro results of the RBNS assay shown in Figure 4.
To address the ability of the ΔRGG truncation to be transported to neurites, we assayed the subcellular location of full length FMRP and the ΔRGG truncation using immunofluorescence. We found that cells expressing full length FMRP and the ΔRGG truncation displayed approximately equal proportions of the total cellular FMRP in their neurites, indicating that the full length protein and the truncation are trafficked to neurites at approximately similar levels (Figure 5F). Based on these results, we conclude that the observed defect in the localization of G-quadruplex-containing transcripts in cells expressing the ΔRGG truncation is likely due to a reduced ability of FMRP to bind the transcript and not a reduced ability of the protein to be trafficked.
To probe the functional relationship between the RGG domain of FMRP and G-quadruplex sequences transcriptome-wide, we fractionated the FMRP rescue lines into soma and neurite fractions and analyzed RNA from those fractions using high-throughput sequencing. We observed enrichments for mRNAs encoding ribosomal proteins and electron transport chain components in the neurites of all samples, indicating that fractionation of the cells was successful (Figure 6—figure supplement 1). Transcriptome-wide measures of RNA localization, as measured by LR values of all genes in the GFP and ΔRGG lines were strongly correlated. This is consistent with neither of these lines containing a localization-competent form of FMRP. Full length FMRP rescue samples were outliers in this analysis compared to the GFP and ΔRGG samples, perhaps due to the active localization regulatory activity of full length FMRP (Figure 6A, Supplementary files 1c, 1d, 1e).
We then compared changes in localization across samples by looking at changes in LR values for all genes. We found that comparing LR values in the full length FMRP rescue to either the GFP rescue or ΔRGG rescue produced highly concordant results (Figure 6—figure supplement 2), consistent with both comparisons involving one functionally active FMRP condition and one functionally inactive FMRP condition. These comparisons were also strongly positively correlated with our original CAD knockout experiment in which FMRP null and wildtype cells were compared (Figure 6—figure supplement 2).
Next, we compared the 3′ UTR G-quadruplex densities of genes that were differentially localized between given rescue conditions. When we compared the GFP rescue samples and full length FMRP rescue samples, we found that genes that were significantly more localized in the FMRP rescue cells contained significantly more G-quadruplex sequences in their 3′ UTRs than expected, consistent with our previous results (Figures 6B and 2D–F). When we performed the same analysis comparing the FMRPΔRGG rescue samples to the full length FMRP rescue samples, we again found that genes whose localization was significantly more efficient in the full length FMRP samples contained significantly more 3′ UTR G-quadruplex sequences than expected (Figure 6C). This suggests that, transcriptome-wide, the RGG domain of FMRP is important for the neurite-localization of RNA molecules that contain G-quadruplex sequences. Consistent with this, we observed no relationship between the G-quadruplex content of an RNA and its differential localization in the GFP rescue and FMRPΔRGG rescue samples (Figure 6—figure supplement 3).
The translational regulatory targets and RNA localization targets of FMRP are distinct pools of transcripts
FMRP is known to regulate mRNA metabolism at the level of RNA localization and translation. We wondered whether the transcripts targeted by these activities were largely the same or distinct. To address this question, we identified FMRP translational regulatory targets by performing ribosomal profiling on wildtype and FMRP null CAD cells. We observed that our ribosome protected fragments displayed strong enrichments for coding regions as well as a strong three nucleotide periodicity, indicating that the ribosome profiling data was of high quality (Figure 7—figure supplements 1–4).
We used the software package Xtail to identify transcripts that displayed significantly different ribosome occupancies in wildtype and FMRP null CAD cells (Figure 7—figure supplement 5, Supplementary File 1f; ). Previous studies had reported that FMRP predominantly negatively regulates translation by inducing ribosome stalls. Since stalls may result in ribosome pileups and increased ribosome densities, we reasoned that FMRP translation targets should have a lower ribosome occupancy in FMRP null cells, even though their rate of translation and protein output is increased in the absence of FMRP (Figure 7A). This is an important consideration, especially when investigating a protein that is believed to induce ribosome stalling. Cycloheximide-based ribosome profiling data informs on the locations of all ribosomes, not just translating ribosomes, and this is why we prefer the term ‘ribosome occupancy’ to ‘translational efficiency’ when referring to this data. We found genes that displayed reduced ribosome occupancy in FMRP null cells compared to wildtype cells were significantly more likely to have been identified as FMRP CLIP targets than expected (Figure 7B;;; ), consistent with FMRP either generally acting to inhibit translation by inducing ribosome stalling or with FMRP generally acting as a translational activator.
We found a significant but weak correlation between the mislocalization (as measured by changes in LR) and translational repression (as measured by changes in ribosome occupancy) of transcripts due to FMRP (R = 0.08, p=4.1e-16). However, when we looked at the transcripts that were statistically significantly affected in the two conditions, we found no significant overlap between the translational regulatory targets and the RNA localization targets of FMRP, suggesting that the protein exerts these activities on largely distinct pools of transcripts (Figure 7C). While the localization targets of FMRP were enriched for genes that regulate transport in cells (Figure 1—figure supplement 7), the translational regulatory targets were enriched for genes that regulate RNA metabolism and for those that regulate synaptic activity (Figure 7—figure supplement 6).
We also found no relationship between the 3′ UTR G-quadruplex content of a transcript and whether or not it was translationally regulated by FMRP (Figure 7D). Identifying transcript features associated with translational regulation by FMRP proved difficult as the transcript features most strongly associated with FMRP translation targets were the GC content and length of the transcript’s CDS (Figure 7—figure supplements 7 and 8). Translational regulatory targets of FMRP were strongly enriched for having GC-poor, long CDS sequences. These effects are difficult to disentangle, however, as transcript GC content and length are correlated with each other in multiple species as well as with a variety of other metrics, including conservation, expression, and RNA secondary structure.
Given that the target pools of the translation and RNA localization activities of FMRP appear to be distinct, we wondered whether these two activities could be functionally separated. To address this, we assayed the ability of a point mutant of FMRP, I304N, to promote localization of G-quadruplex-containing transcripts. The I304N mutation is in one of the KH domains of FMRP and renders the protein unable to interact with polysomes and unable to repress translation. As with the ΔRGG truncation, we created CAD cells that express the I304N mutant by rescuing FMRP-null cells through site-specific integration of an I304N cDNA using Cre-lox recombination. We fractionated these cells into soma and neurite fractions, and then sequenced RNA collected from both fractions. Quality control metrics for the fractionation indicated that it was of high quality (Figure 1—figure supplements 6, 8 and 9). We then compared RNA localization, transcriptome-wide, between FMRP-null cells rescued with GFP and cells rescued with I304N.
We found that transcripts that were more efficiently localized in the I304N sample contained significantly more G-quadruplexes than expected, indicating that the I304N mutant retains the ability to promote the localization of G-quadruplex-containing transcripts (Figure 7E, Supplementary file 1g). In support of this result, we found that wildtype FMRP and the I304N mutant were transported to neurites with approximately equal efficiencies, as had been previously reported (Figure 7—figure supplement 9;; ).
When we compared localization data from cells expressing full length, wildtype FMRP to those expressing the I304N mutant, we found that the mutant was deficient in promoting the localization of G-quadruplex-containing messages compared to the wildtype (Figure 7—figure supplement 10, Supplementary file 1h). However, the I304N mutant is approximately four fold more lowly expressed than the wildtype in these cells (Figure 7—figure supplement 11). This decreased expression of the I304N mutant is consistent with previous reports of reduced I304N expression in I304N mouse mutants. Given that in our system the wildtype and I304N mutant proteins are integrated and expressed from the same locus using the same promoter, we propose that this decrease in I304N protein expression is due to decreased protein stability.
From these results, we conclude that an FMRP mutant that is unable to regulate translation is still able to regulate the localization of G-quadruplex-containing transcripts. We propose a model in which the recognition of a G-quadruplex sequence within the 3′ UTR of a transcript by the RGG domain of FMRP is associated with localization of the transcript. Conversely, the recognition of some as-yet unidentified transcript feature by one or both of the KH domains of FMRP may be associated with translational regulation (Figure 7F). This transcript feature, if it exists, has been difficult to identify as both bioinformatic sequence analysis of the translational regulation targets of FMRP and the RNA sequences specifically bound by the KH domains of FMRP in the RBNS experiment yielded no strongly enriched motifs.
This model is supported by three observations. First, although some studies have found that the RGG domain of FMRP is required for efficient interaction of the protein with polyribosomes, other studies have found that the RGG domain of FMRP is at least partially dispensable for this interaction while the KH domains are absolutely required. Second, the I304N mutation, which is in one of the KH domains, abolishes polyribosome association and translation repression activity, but not localization activity. Third, G-quadruplex sequences are unable to compete with polysomes for binding to FMRP. Taken together, these findings support the idea that the dual functionalities of FMRP are driven by distinct binding capabilities of its different RNA binding domains.
Discussion
Hundreds to thousands of transcripts are asymmetrically distributed within cells, yet the mechanisms that regulate trafficking are known for only a handful. In this study we have used genome engineering, subcellular fractionation, and high-throughput sequencing to identify transcripts that depend on FMRP for transport in neuronal cells. These FMRP localization targets displayed a large enrichment for G-quadruplex sequences, particular in their 3′ UTRs, suggesting that FMRP specifically recognizes these sequences to target them for transport. G-quadruplex sequences were not enriched in the translational regulatory targets of FMRP as identified by ribosome profiling. In fact, no recognizable sequence motif was strongly enriched in the translational regulatory targets beyond a negative correlation with GC content. These apparent dual modes of target recognition and the lack of clear specificity in the translational regulatory targets may explain some of the previously reported conflicting results in regards to the preferred RNA binding sites of FMRP.
Our results raise the question as to how an RNA that is targeted to neurites through the action of FMRP is not subject to translational regulation by FMRP. Although we did not test these hypotheses here, we propose these potential mechanisms. We found that binding events that lead to RNA transport frequently occur in the 3′ UTR, while other studies have found that binding events associated with translation regulation occur in the open reading frame. Perhaps where FMRP contacts the RNA plays a role in the regulatory effects it can exert. Alternatively, the two activities of the protein could be differentially regulated spatially or in response to stimulus.
FMRP has long been known to bind to G-quadruplex sequences, and G-quadruplex sequences have been shown to be sufficient for transport to neurites. In this work, we formally and directly combine those facts to functionally relate the ability of FMRP to bind G-quadruplexes with its ability to transport RNA molecules. It is important to note that we cannot formally prove that the G-quadruplex sequences enriched in FMRP localization targets are actually folded in cells. Recent reports have demonstrated that the majority of RNA sequences that have the ability to fold into G-quadruplex structures in vitro may be generally unfolded in cells. Still, previous reports and our data demonstrate that the G-quadruplexes must be folded in order to be efficiently bound by FMRP, and G-quadruplex sequences have been reported to be under purifying selection.
No clear links have yet been found between the mislocalization of a specific transcript or transcripts in FXS neurons and FXS phenotypes. The relative contribution of the RNA localization and translational regulation activities of FMRP to FXS phenotypes similarly remain unclear. However, the fact that the I304N mutant, which is unable to inhibit translation but still able to regulate RNA localization, is associated with FXS phenotypes clearly points to the translational regulatory activity of FMRP being important. Further work is needed to more fully understand mechanistic links between RNA localization and neurological diseases including FXS.
For the vast majority of localized transcripts, in neurons and elsewhere, the RBP/RNA interactions that mediate transport are completely unknown. Classically, experiments designed to address these questions have focused on one transcript at a time and take the approach of systematic deletions and/or mutations to identify minimal sequence elements that regulate localization. While these experiments have been successful and provided key insights for the field, they are quite labor-intensive, and it is difficult to derive general rules that govern RNA localization from isolated, single-transcript examples. RBP-perturbation experiments followed by transcriptomic profiling have been highly successful in elucidating mechanisms that underlie other RNA metabolic processes, including pre-mRNA processing, translation, and decay. By extending these techniques to the study of RNA localization, we envision this study as providing a framework for the investigation of other RBPs and their effects on RNA trafficking. Given that RNA mislocalization has been associated with a range of neurological diseases, these studies can lay groundwork that links molecular defects to observed phenotypes.
Construction of an FMRP-null CAD line
CAD cell lines were authenticated using STR profiling and were found to be mycoplasma negative. The guide RNA sequence AAATTATCAGCTGGTAATTT was cloned into pX330 (gift of F. Zhang) using the BbsI sites. This plasmid was then transfected into CAD cells using Lipofectamine LTX. Forty-eight hours after transfection, the cells were sorted to single cells using a flow cytometer and allowed to grow without interference for two weeks. Clones were screened for FMRP expression using a polyclonal FMRP antibody (MBL International RN016P). Lesions at the locus of cutting were identified by PCR using genomic DNA to amplify the locus followed by Topo cloning of the PCR fragment and Sanger sequencing of individual bacterial colonies.
Sequencing of subcellular transcriptomes from wildtype and FMRP null CAD cells
CAD cells were grown in DMEM/F12 (Gibco 11320033) supplemented with 10% FBS at 37C in 5% CO2. To fractionate CAD cells into soma and neurite fractions, CAD cells were plated on porous, transwell membranes that had a pore size of 1.0 micron (Corning 353102). One million CAD cells were plated on each membrane. These membranes fit in one well of a six well plate, and six membranes were combined to comprise one single preparation. After allowing the cells to attach, the cells were induced to differentiate into a more neuronal state through the withdrawal of serum. Cells were then differentiated on the membranes for 48 hr.
To fractionate the cells, the membranes were washed one time with PBS. One mL of PBS was added to the top (soma) side of the membrane. The top side of the membrane was then scraped repeatedly and thoroughly with a cell scraper and the soma were removed into an ice-cold 15 mL falcon tube. After scraping, the membranes were removed from their plastic housing with a razor blade and soaked in 500 µL RNA lysis buffer (Zymo R1050) at room temperature for 15 min to make a neurite lysate. During this time, the 6 mL of soma suspension in PBS was spun down and resuspended in 600 µL PBS. 100 µL of this soma sample was then carried forward for RNA isolation using the Zymo QuickRNA MicroPrep kit (Zymo R1050). In parallel, RNA was also isolated from the 500 µL neurite lysate using the same kit. Typically, the neurite RNA yield from the six combined membranes was 500–1000 ng. The efficiency of the fractionation was assayed by Western blotting using anti-beta-actin (Sigma A5441, 1:5000) and anti-Histone H3 (Abcam ab10799, 1:10000) antibodies.
PolyA-selected, stranded libraries were constructed using 25 ng total RNA and an Illumina Neoprep library preparation system. The resulting libraries were then sequenced on an Illumina NextSeq 500 sequencer using paired-end, 75 bp reads. Approximately 40 million read pairs were obtained per sample. Each condition (wildtype and FMRP null; soma and neurite) was prepared and sequenced in triplicate for a total of 12 samples.
Quantification of RNA localization from CAD subcellular sequencing data
Transcript abundances were calculated from read files using kallisto (CAD Fmr1 knockout) or using salmon v0.11.1 (CAD Fmr1 rescue samples, FXS iPS samples) with the options --seqBias and --gcBias. Transcript abundances were then collapsed to gene abundances using txImport. LR values for genes were calculated as log2 of the ratio of neurite/soma normalized counts for a gene produced by DESeq2 using the salmon/tximport calculated counts. Genes with less than 10 counts in any sample were excluded from further analyses. To identify genes whose LR values significantly changed across conditions, the Xtail software package was used. Xtail is designed to process ribosome profiling data and identify genes whose ribosome occupancy changes across conditions. However, since ribosome occupancy is simply a ratio of expression count values (ribosome footprints/RNAseq), we reasoned that since LR is also a ratio of expression count values (neurite/soma), Xtail could be used to identify genes whose LR value changed across conditions. For further analyses of this data, mislocalized genes were defined as those with a FDR of less than 0.01.
Identification of transcript features associated with mislocalized genes
To ask if previously identified FMRP-interacting transcripts were enriched in our set of mislocalized genes, we defined FMRP-interacting transcripts as the intersection of RNA targets identified in two earlier studies as was previously done.
To identify 6mer sequences enriched in the 3′ UTRs of mislocalized genes, we calculated the abundance of all 6mers in the UTRs of mislocalized genes and, as a control, in the UTRs of expressed but non-mislocalized genes. These abundances were then compared using a Fishers exact test, and the resulting p values were corrected for multiple hypothesis testing using the Benjamini-Hochsberg method.
To computationally identify predicted G-quadruplex sequences, we used two approaches. First, to identify WGGA sequences separated by variable length linkers, we searched sequences using the regular expression (?=([AU]GGA(.{0,6})[AU]GGA(.{0,6})[AU]GGA(.{0,6})[AU]GGA)). Alternatively, we analyzed sequences using a sliding window approach and RNAfold. The window was 80 nt wide and slid 20 nt at a time. The sequence within each window was analyzed using RNAfold and the -g option. Nucleotides with a ‘+’ for their predicted structure status were designated as nucleotides participating in a quadruplex.
For analyses involving experimentally defined G-quadruplex sequences, data was taken from previously published experiments using RNA purified from mouse embryonic stem cells that utilized RT stops that occurred with differential frequency in G-quadruplex promoting (potassium) conditions and G-quadruplex inhibiting (lithium) conditions. The data taken from this paper contained RT stop sites, the 60 nt upstream of the stop site, and the frequency at which those sites were observed in the potassium and lithium conditions. RT stops representing G-quadruplexes were defined as those which were observed at least five times more frequently in the potassium data than in the lithium data. For those sites, the G-quadruplex region was defined as the 60 nt immediately upstream of the stop.
Cliff’s delta values representing the effect sizes associated with each transcript feature and its association with FMRP-mediated localization were calculating using the orddom package in R.
G-quadruplex conservation analyses
To ask if G-quadruplexes were positionally conserved, PhyloP scores were calculated for all G nucleotides in all 3′ UTRs. If the G nucleotides were predicted by RNAfold to be participating in quadruplexes as discussed above, their scores were put in one bin. If they were not predicted to be participating in quadruplexes, they were put in another bin. The scores of the G nucleotides in the two bins were then compared.
FXS iPSC line generation and iPSC culture iPSCs were generated by transducing control and FXS patient fibroblasts with Sendai virus from the Cytotune 2.0 Reprogramming Kit (Life Technologies) per the manufacturer’s protocol. Briefly, early passage fibroblasts were cultured in fibroblast medium (10% ES-qualified FBS, 0.1 mM NEAA, 55 µM β-mercaptoethanol, high glucose DMEM with Glutamax) for two days. On day 0, fibroblasts were transduced with Sendai virus encoding KOS, hc-Myc, hKlf4, each at an MOI of 5. Cells were fed with fibroblast medium every other day for one week. On day 7, cells were passaged onto vitronectin (Life Technologies) coated dishes at a density of 250,000 to 500,000 cells/well. Beginning on day 8, cells were fed every day in Essential eight medium (Life Technologies) and colonies began to emerge within another 7–10 days. Individual iPSC colonies were manually picked and transferred to a dish coated with either vitronectin or Matrigel (BD) and expanded as clonal lines. All iPSC lines were karyotyped (WiCell) and characterized for expression of markers of pluripotency using immunofluorescence and RT-PCR. Additionally, we confirmed loss-of-function of FMR1 in our FXS patient iPSC lines by taqman assays for FMR1 mRNA and western blotting for FMRP. iPSCs were maintained on Matrigel coated dishes and fed every day with complete mTesR1 medium (Stem Cell Technologies). iPSCs were passaged every 5–7 days using ReLeSR (Stem Cell Technologies).
FXS iPS line differentiation into motor neurons
Motor neurons were generated using an improved, suspension culture-based protocol based on previously published Dual-Smad inhibition approaches. iPSCs were grown as clusters in suspension, and differentiated in a set-wise fashion as outlined in Supp. Figure 3a. Briefly, clusters were exposed to Smad and ROCK inhibition and WNT activation during the first 6 days, followed by activation of the retinoic and sonic hedgehog pathways. At day 10 the clusters were dissociated, and single cells were plated on membranes coated with Matrigel (Corning) in maturation media until d18-21 when MNs were analyzed.
Fractionation of iPS neurons into soma and neurite fractions
Generally, iPS neurons were fractionated in a very similar method as the CAD cells. However, since the iPS neurons usually contained less material, instead of combining six wells together into one prep as was done for the CAD cells, between 6 and 12 wells were combined together. After mechanical fractionation by scraping into soma and neurite fractions and RNA isolation using the Zymo Quick RNA Microprep Kit, between 100 and 500 ng of neurite RNA was obtained.
Fractionation efficiency was monitored by protein dot blot using the beta-actin and histone H3 antibodies described above. PolyA-selected, stranded RNAseq libraries were constructed using the Kapa mRNA Hyperprep kit, 100 ng of total RNA, and 15 PCR cycles of library amplification. Each condition (FXS and unaffected; soma and neurite) was fractionated, prepared, and sequenced with four replicates for a total of 16 samples. Samples were sequenced using paired-end, 150 nt sequencing on an Illumina NovaSeq. Approximately 30 million read pairs were obtained per sample.
Analysis of iPS neuron subcellular transcriptome data
Raw sequencing data from the iPS soma and neurite samples were analyzed using salmon and tximport as described above. After analysis of changes in RNA localization between FXS and unaffected samples using Xtail, very few genes met a reasonable FDR threshold for being significantly different between conditions. This may be a reflection of the increased variance in expression values in these samples relative to the CAD samples, perhaps due to slight variations between preps in the differentiation from iPS cells into motor neurons. For the analysis of G-quadruplex densities in mislocalized genes, mislocalized genes were identified as those who had a log2 fold change in LR across conditions (FXS vs unaffected) of at least 0.25.
RNA Bind-n-Seq protein purification and sequence analysis
RosettaE. colicells were transformed with pGEX6 bacterial expression constructs (GE Healthcare) harboring GST-SBP (streptavidin binding peptide)-RGG or the two KH domains from mouse FMRP. The RGG domain was defined as residues 478–614 and the KH domains were defined as residues 222–315 from mouse FMRP1. Cultures were grown in LB broth until the optical density reached ~0.8. Cultures were brought to 16°C and induced with IPTG overnight. Cells were then harvested and lysed in lysis buffer (25 mM Tris-HCl, 150 mM NaCl, 3 mM MgCl2, 1% Triton X-100, 500units/per 1L culture Benzonase Nuclease, 20 mg/L Lysozyme, Pierce Protease Inhibitor tablets). Cell pellets were then sonicated, incubated for 30 min on ice, and centrifuged at 12500 rpm for 40 min. Supernatants were passed through a 0.45 micron filter and GST-tagged proteins were purified using GST-trap FF columns (GE). Samples were further subjected to size exclusion chromatography (Superdex 200 Increase 10/300 GL column (GE)). Pure fractions were pooled together and concentrated by centrifugation (Amicon Ultra-0.5mL Centrifugal Filter Units). Purity was assessed by PAGE and Coomassie stain.
The RNA Bind-n-Seq assay was performed similar to previously described. Briefly, RNA with a random region of 40nt was prepared by in vitro transcription. The RNA pool resolved by PAGE and purified. Concentrated RNA was heated at 85C for 5 min in the presence of 150 mM KCl or LiCl and allowed to cool for at least 3 min to allow for folding. Binding reactions were performed as previously described. All wash and binding buffers contained either 150 mM KCl or LiCl. Protein-RNA complexes were eluted, RNA isolated and prepared for sequencing as previously described.
Sequence enrichments in RNA Bind-n-Seq data were obtained in three ways. First, kmer frequencies (k = 3–6) were computed in protein-bound libraries and compared to kmers in the input library. For each kmer, the ratio of its frequency in the protein-bound library to the input library results in an enrichment or ‘R’ value for every kmer, as was previously reported. To identify G quadruplex sequences, we determined the fraction of protein-bound reads with matches to a variety of G quadruplex motifs (e.g. GGGN1-7GGGN1-7 GGGN1-7GGG) and compared that to the number of input reads with the same motif. Lastly, we used RNAfold version 2.4.11 to predict G quadruplexes (RNAfold -g option) in the 40 nucleotide randomized regions of input and bound RNAs. As with the pattern match approach, the ratio of protein-bound to input reads predicted to fold into G quadruplexes was computed. In each case reads were subsampled for estimates. Error bars shown in figures represent standard deviation from mean across subsamples.
Fluorescence polarization assay
RNAs labeled at the 3′ end with 6-FAM were purchased from Integrated DNA Technologies. The RNA sequences used were: 5’-GGGAGGGAGGGAGGGUA-6FAM-3’ (rG4) and 5’-CCCCCCUCCCCCCU-6FAM-3’ (CTRL RNA). rG4 was heated to 100°C in the presence of 150 mM KCl (promoting G-quadruplex formation) or 150 mM LiCl (disrupting G-quadruplex formation) for 3 min and allowed to cool down to room temperature for at least 15 min. rG4 was then mixed with binding buffer containing 150 mM KCl (or LiCl), 10 mM Tris-HCl and 5% glycerol. Cation usage (K+ or Li+) was kept constant throughout the assay. The RGG domain of FMRP was purified and then serially diluted with binding buffer to concentrations between 1 µM to 2 nM. The RGG domain was then incubated with 10 nM of rG4 in potassium, rG4 in lithium or CTRL RNA. After incubation for 5 min at 25°C, plates were centrifuged at 1000 rpm for 1 min. Fluorescence polarization was monitored with a PHERAstar plate reader (BMG Labtech) at 26–27°C.
Construction of an FMRP-null CAD line with single LoxP cassette
CAD LoxP cell lines were received from the lab of Eugene Makeyev. This line contains a single loxP cassette in the genome of the cells to facilitate recombination of exogenous constructs. A knockout insertion cassette was introduced to exon 6 of the endogenous Fmr1 gene via CRISPR-Cas9 technology to generate CAD LoxP FMRP KO cells. This cassette includes stop codons in all frames as well as a strong polyadenylation signal. 300 nt of homology on either side of the gRNA cut site was included to facilitate homology directed repair. A G418 resistance gene was included to select for integration. pX330 was used to express Cas9 and the guide RNA sequence AAATTATCAGCTGGTAATTT. Following selection with G418, cells were sorted to single cells using a flow cytometer and allowed to expand for two weeks. Clones were screened for insertion of the cassette by PCR as well as FMRP mRNA and protein depletion determined by qPCR, RNA-seq and Western Blot Analysis with a monoclonal FMRP antibody (Proteintech 66548). Lesions at the locus of cutting were identified by PCR using genomic DNA to amplify the locus followed by Topo cloning of the PCR fragment and Sanger sequencing of individual bacterial colonies.
Expression of Fmr1 rescue constructs in CAD cells
CAD LoxP FMRP KO cell lines were plated in 12-well plates at 1.0 to 1.5 × 105 cells per well in an DMEM:F12 supplemented with 10% Equafetal 12 to 18 hr before transfection. Cells were then co-transfected with a derivative of pRD-RIPE (containing one of three Fmr1 rescue cDNAs and Firefly Luciferase fused with one of two 3’UTRs) blended with 1% (wt/wt) of a Cre-encoding plasmid (pCAGGS-Cre). Fmr1 cDNAs were derived from cDNA clone BC079671.1. To transfect one well of a 12-well plate, 0.5 μg of purified plasmid was mixed with 2 μL Lipofectamine LTX reagent, 1 µL PLUS reagent and 50 μL Opti-MEM following the manufacturer's protocol. Cells were incubated with the transfection mixtures overnight, the medium was changed and the incubation continued for another 24 hr before addition of puromycin (5 µg/ml). Incubation with puromycin continued for several days until untransfected control wells were depleted of cells. The cultures with stably integrated constructs were expanded in a full growth medium. Lysates were collected following 2 µg/mL doxycycline induction to assay construct expression via western blot.
Immunoblot of FMRP rescue constructs
Expression of rescue constructs in the CAD FMRP KO cell lines were determined by Western blot analysis. Cells with integrated rescue constructs were plated in 6-well plates at 2–3 × 105 cells per well in duplicate. Each cell line was grown in full growth media or full growth media supplemented with 2 µg/mL doxycycline for 48 hr. Lysates were collected with 200 µL RIPA buffer, incubated on ice for 15 min then passed through a 20G needle 20 times. Lysates were stored at −80°C. Denatured lysates were separated by PAGE on 4–12% Bis-Tris gradient gels (Invitrogen) along with Spectra Multicolor Broad Range (Fisher Scientific) using MOPS SDS NuPAGE Running Buffer (Invitrogen) and NuPAGE LDS Sample Buffer (Invitrogen) on ice at 200 V for 1 hr. Gels were transferred to PVDF membranes (Millipore) using NuPAGE Transfer Buffer (Invitrogen) at 15 V for 55 min before being washed three times, 5 min each with PBST at room temperature (RT) with agitation and blocked with 5% Milk Powder (Sigma) in PBST for 1 hr at RT with agitation. Blots were again washed three times, 5 min each in PBST at RT with agitation before being incubated in 1:5000 FMRP mouse monoclonal (Proteintech) primary antibody in 2% Milk Powder in PBST overnight at 4C with agitation or with 1:10,000 Histone H3 mouse monoclonal antibody (Abcam) in 2% milk powder in PBST for 2 hr at room temperature with agitation. Blots were washed three times, 5 min each at RT with agitation and then transferred to Anti-mouse IgG HRP-conjugated secondary antibody in 2% Milk Powder in PBST and incubated at RT for 2 hr. Blots were washed again as previously described and visualized using WesternBright HRP Substrate Kit (Advansta).
smFISH of reporter transcripts
CAD LoxP FMRP KO cells with Integrated Rescue constructs were plated on PDL coated glass coverslips (neuVitro) within 12-well plates at approximately 2.5 × 104 cells per well in full growth media. Cells were allowed to attach for 2 hr before changing to serum depleted media supplemented with 2 µg/mL doxycycline. Cells were allowed to express constructs and differentiate for 48 hr. Cells were washed once with PBS before being fixed in 3.7% formaldehyde in PBS for 10 min at room temperature then washed twice with PBS before permeabilization with 70% Ethanol at 4°C for 6–8 hr. Cells are incubated in smFISH Wash Buffer at room temperature for 2–5 min. Per hybridization reaction, 2 µL of Stellaris FISH Probes, Firefly Luc with Quasar 670 Dye were added to 200 µL of Hybridization Buffer. An empty opaque tip box is prepared with wet paper towels below with parafilm covering the top. Hybridization buffer with probes (200 µL per reaction) was ‘beaded’ on top of the parafilm and the PDL coated glass coverslips were placed cell side down onto ‘beaded’ buffer. The entire tip box is incubated at 37°C over night. Glass coverslips were transferred to fresh 12-well plates cell side up and incubated with smFISH Wash Buffer at 37°C in the dark for 30 min. Buffer was then replaced with fresh smFISH Wash Buffer supplemented with 100 ng/mL DAPI and incubated in the dark at 37°C. DAPI stain was replaced with fresh smFISH Wash Buffer and incubated for 5 min at room temperature. Coverslips were then mounted onto slides with 6 µL Fluoromount G and sealed with nail polish. Slides were imaged on a widefield DeltaVision Microscope with consistent laser intensity and exposure times across samples.
smFISH quantification
Experimental parameters within FISH-quant were set to match widefield DeltaVision microscope and the Stellaris FISH probes. The excitation and emission wavelengths used were 547 nm and 583 nm respectively which were recorded by a 60X objective with 1.4 numerical aperture with 1.33 refractive index oil. This was captured by a camera such that pixel sizes in the xy were 98.4 nm wide and z pixels a 398 nm wide. Cell outlines were drawn using cell autofluorescence in the FITC channel where somas and neurites were treated as separate cells. Images were first filtered with a 3D 2x gaussian method using the default parameters. Pre-detection was conducted, and spots were fit using FISH-quant default settings and a pixel-intensity threshold set to overestimate detected spots. All thresholding parameters were set tightly around each mean population to exclude gross outliers. Averaged detected spots were inspected for spherical character to ensure quality of detection. These detection settings were the same for every soma and neurite imaged.
Immunofluorescence for HA tagged FMRP rescues in differentiated neurons
CAD FMRP KO cells with doxycycline inducible HA-tagged rescue constructs were plated on top of PDL coated glass coverslips (neuVitro) within 12-well plates at approximately 2.5 × 104 cells per well in in full growth media supplemented with 2.0 µg/mL doxycycline for 2 hr to allow attachment. Media was removed and replaced with differentiation media (lacking serum) supplemented with 2.0 µg/mL doxycycline for an additional 48 hr to induce neurite growth and rescue construct expression. Media was removed and cells were washed with PBS before being fixed with 3.7% formaldehyde at room temperature for 10 min. Cells were washed twice with PBS following fixation for 5 min each. Cells were permeabilized for 30 min at room temperature with 0.3% Triton-X in PBS. Primary HA antibody (GenScript A01244-100) was diluted 1:2000 in PBS containing 1% BSA and 0.3% Triton-X for 1 hr at 37°C. Cells were then rinsed three times with PBS before adding 100 ng/mL DAPI and fluorescent secondary antibody (Cell Signaling Technology 4413S) diluted 1:500 in PBS containing 1% BSA and 0.3% Triton-X for 1 hr at room temperature. Cells were again rinsed three times with PBS then mounted onto slides with Fluoromount G and sealed with nail polish. Slides were imaged on a widefield DeltaVision Microscope with consistent laser intensity and exposure times across samples.
CLIP-qPCR
One 15 cm plate of cells was used per condition. Expression of the HA-tagged FMRP constructs, Firefly luciferase, and Renilla luciferase were induced with doxycycline for 48 hr prior to the start of the experiment. To crosslink, cells were washed once with cold PBS, then irradiated with 400 mJ / cm2 of 254 nm ultraviolet light in a Stratlinker while on ice. Cells were then scraped in 5 mL PBS, centrifuged for 5 min at 2000 g at 4°C, and resuspended in 400 µL lysis buffer (20 mM Tris pH 7.5, 100 mM KCl, 5 mM MgCl2, 0.5% NP-40, 1 mM DTT, 1 mM PMSF). 3 µL of RNase inhibitor were added, and the lysate was incubated on ice for 10 min, then spun at 10,000 g for 15 min at 4°C.
Anti-HA magnetic beads (Pierce) were prepared by washing them three times with buffer A (50 mM Tris pH 7.5, 150 mM NaCl, 0.05% Tween). Lysate was then added to the beads and incubated at 4°C with rotation for 3 hr. Beads were then washed three times with buffer A and incubated with 10U DNase (ThermoFisher) in buffer A supplemented with the 1X buffer that accompanied the enzyme. Beads were then incubated with 20 µg proteinase K (ThermoFisher) in proteinase K buffer (20 mM Tris pH 7.5, 0.1% SDS, 100 mM NaCl) at 55°C for 15 min. The supernatant was then removed from the beads and RNA was isolated using an RNA Clean and Concentrator kit (Zymo).
Firefly luciferase and Renilla luciferase transcript levels were monitored in input and IP samples using Taqman qPCR with probe sets supplied by Life Technologies. Firefly luciferase RNA was quantified using a VIC-labeled probe while Renilla luciferase RNA was quantified using a FAM-labeled probe. The reaction was performed using Taqman Fast Advanced Master Mix (Life Technologies).
Ribosome footprinting of CAD cells
CAD cells were grown in the absence of serum for 48 hr to induce neuronal differentiation. Ribosome footprint libraries and companion RNAseq libraries were then produced using the Truseq Ribo Profiling Kit from Illumina according to the manufacturer’s instructions. Libraries were sequenced on an Illumina NextSeq sequencer, with about 40 million reads being obtained per sample. Three techincal replicates were performed per condition (WT and knockout; ribosome protected fragments (RPF) and RNAseq) for a total of 12 samples.
Gene level abundance estimates from the RPF and RNAseq data were performed using kallisto and tximport as described above. Ribosome occupancy values and their changes between wildtype and knockout cells were then calculated using Xtail.
References 87
- 1.
Anderson BR, Chopra P, Suhl JA, Warren ST, Bassell GJ. Identification of consensus binding sites clarifies FMRP binding determinants. Nucleic Acids Research. 2016;44:6649-6659.
Not in our library10.1093/nar/gkw593
- 2.
Ascano M, Mukherjee N, Bandaru P, Miller JB, Nusbaum JD, Corcoran DL, Langlois C, Munschauer M, Dewell S, Hafner M, Williams Z, Ohler U, Tuschl T. FMRP targets distinct mRNA sequence elements to regulate protein expression. Nature. 2012;492:382-386.
Not in our library10.1038/nature11737
- 3.
Bertrand E, Chartrand P, Schaefer M, Shenoy SM, Singer RH, Long RM. Localization of ASH1 mRNA particles in living yeast. Molecular Cell. 1998;2:437-445.
Not in our library10.1016/s1097-2765(00)80143-4
- 4.
Blackwell E, Zhang X, Ceman S. Arginines of the RGG box regulate FMRP association with polyribosomes and mRNA. Human Molecular Genetics. 2010;19:1314-1323.
Not in our library10.1093/hmg/ddq007
- 5.
Blice-Baum AC, Mihailescu MR. Biophysical characterization of G-quadruplex forming FMR1 mRNA and of its interactions with different fragile X mental retardation protein isoforms. RNA. 2014;20:103-114.
Not in our library10.1261/rna.041442.113
- 6.
Bray NL, Pimentel H, Melsted P, Pachter L. Near-optimal probabilistic RNA-seq quantification. Nature Biotechnology. 2016;34:525-527.
Not in our library10.1038/nbt.3519
- 7.
Brown V, Jin P, Ceman S, Darnell JC, O'Donnell WT, Tenenbaum SA, Jin X, Feng Y, Wilkinson KD, Keene JD, Darnell RB, Warren ST. Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell. 2001;107:477-487.
Not in our library10.1016/s0092-8674(01)00568-2
- 8.
Cajigas IJ, Tushev G, Will TJ, tom Dieck S, Fuerst N, Schuman EM. The local transcriptome in the synaptic neuropil revealed by deep sequencing and high-resolution imaging. Neuron. 2012;74:453-466.
Not in our library10.1016/j.neuron.2012.02.036
- 9.
Chambers SM, Fasano CA, Papapetrou EP, Tomishima M, Sadelain M, Studer L. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nature Biotechnology. 2009;27:275-280.
Not in our library10.1038/nbt.1529
- 10.
Chen E, Sharma MR, Shi X, Agrawal RK, Joseph S. Fragile X mental retardation protein regulates translation by binding directly to the ribosome. Molecular Cell. 2014;54:407-417.
Not in our library10.1016/j.molcel.2014.03.023
- 11.
Coffee B, Keith K, Albizua I, Malone T, Mowrey J, Sherman SL, Warren ST. Incidence of fragile X syndrome by newborn screening for methylated FMR1 DNA. The American Journal of Human Genetics. 2009;85:503-514.
Not in our library10.1016/j.ajhg.2009.09.007
- 12.
Darnell JC, Jensen KB, Jin P, Brown V, Warren ST, Darnell RB. Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function. Cell. 2001;107:489-499.
Not in our library10.1016/s0092-8674(01)00566-9
- 13.
Darnell JC, Fraser CE, Mostovetsky O, Stefani G, Jones TA, Eddy SR, Darnell RB. Kissing complex RNAs mediate interaction between the Fragile-X mental retardation protein KH2 domain and brain polyribosomes. Genes & Development. 2005a;19:903-918.
Not in our library10.1101/gad.1276805
- 14.
Darnell JC, Mostovetsky O, Darnell RB. FMRP RNA targets: identification and validation. Genes, Brain and Behavior. 2005b;4:341-349.
Not in our library10.1111/j.1601-183x.2005.00144.x
- 15.
Darnell JC, Van Driesche SJ, Zhang C, Hung KY, Mele A, Fraser CE, Stone EF, Chen C, Fak JJ, Chi SW, Licatalosi DD, Richter JD, Darnell RB. FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell. 2011;146:247-261.
Not in our library10.1016/j.cell.2011.06.013
- 16.
Dictenberg JB, Swanger SA, Antar LN, Singer RH, Bassell GJ. A direct role for FMRP in activity-dependent dendritic mRNA transport links filopodial-spine morphogenesis to fragile X syndrome. Developmental Cell. 2008;14:926-939.
Not in our library10.1016/j.devcel.2008.04.003
- 17.
Didiot MC, Tian Z, Schaeffer C, Subramanian M, Mandel JL, Moine H. The G-quartet containing FMRP binding site in FMR1 mRNA is a potent exonic splicing enhancer. Nucleic Acids Research. 2008;36:4902-4912.
Not in our library10.1093/nar/gkn472
- 18.
Dominguez D, Freese P, Alexis MS, Su A, Hochman M, Palden T, Bazile C, Lambert NJ, Van Nostrand EL, Pratt GA, Yeo GW, Graveley BR, Burge CB. Sequence, structure, and context preferences of human RNA binding proteins. Molecular Cell. 2018;70:854-867.
Not in our library10.1016/j.molcel.2018.05.001
- 19.
Du ZW, Chen H, Liu H, Lu J, Qian K, Huang CL, Zhong X, Fan F, Zhang SC. Generation and expansion of highly pure motor neuron progenitors from human pluripotent stem cells. Nature Communications. 2015;6:6626.
Not in our library10.1038/ncomms7626
- 20.
Ephrussi A, Dickinson LK, Lehmann R. Oskar organizes the germ plasm and directs localization of the posterior determinant Nanos. Cell. 1991;66:37-50.
Not in our library10.1016/0092-8674(91)90137-n
- 21.
Farina KL, Huttelmaier S, Musunuru K, Darnell R, Singer RH. Two ZBP1 KH domains facilitate beta-actin mRNA localization, granule formation, and cytoskeletal attachment. Journal of Cell Biology. 2003;160:77-87.
Not in our library10.1083/jcb.200206003
- 22.
Farris S, Ward JM, Carstens KE, Samadi M, Wang Y, Dudek SM. Hippocampal subregions express distinct dendritic transcriptomes that reveal differences in mitochondrial function in CA2. Cell Reports. 2019;29:522-539.
Not in our library10.1016/j.celrep.2019.08.093
- 23.
Feng Y, Absher D, Eberhart DE, Brown V, Malter HE, Warren ST. FMRP associates with polyribosomes as an mRNP, and the I304N mutation of severe fragile X syndrome abolishes this association. Molecular Cell. 1997;1:109-118.
Not in our library10.1016/s1097-2765(00)80012-x
- 24.
Ferrandon D, Elphick L, Nüsslein-Volhard C, St Johnston D. Staufen protein associates with the 3'UTR of bicoid mRNA to form particles that move in a microtubule-dependent manner. Cell. 1994;79:1221-1232.
Not in our library10.1016/0092-8674(94)90013-2
- 25.
Greenblatt EJ, Spradling AC. Fragile X mental retardation 1 gene enhances the translation of large autism-related proteins. Science. 2018;361:709-712.
Not in our library10.1126/science.aas9963
- 26.
Gumy LF, Yeo GS, Tung YC, Zivraj KH, Willis D, Coppola G, Lam BY, Twiss JL, Holt CE, Fawcett JW. Transcriptome analysis of embryonic and adult sensory axons reveals changes in mRNA repertoire localization. RNA. 2011;17:85-98.
Not in our library10.1261/rna.2386111
- 27.
Guo JU, Bartel DP. RNA G-quadruplexes are globally unfolded in eukaryotic cells and depleted in Bacteria. Science. 2016;353:aaf5371.
Not in our library10.1126/science.aaf5371
- 28.
Hardin CC, Watson T, Corregan M, Bailey C. Cation-dependent transition between the quadruplex and Watson-Crick hairpin forms of d(CGCG3GCG). Biochemistry. 1992;31:833-841.
Not in our library10.1021/bi00118a028
- 29.
Huang YS, Carson JH, Barbarese E, Richter JD. Facilitation of dendritic mRNA transport by CPEB. Genes & Development. 2003;17:638-653.
Not in our library10.1101/gad.1053003
- 30.
Hudish LI, Bubak A, Triolo TM, Niemeyer CS, Sussel L, Nagel M, Taliaferro JM, Russ HA. Modeling Hypoxia-Induced neuropathies using a fast and scalable human motor neuron differentiation system. Stem Cell Reports. 2020;12:003.
Not in our library10.1016/j.stemcr.2020.04.003
- 31.
Huppert JL, Balasubramanian S. G-quadruplexes in promoters throughout the human genome. Nucleic Acids Research. 2007;35:406-413.
Not in our library10.1093/nar/gkl1057
- 32.
Ingolia NT, Ghaemmaghami S, Newman JR, Weissman JS. Genome-wide analysis in vivo of translation with nucleotide resolution using ribosome profiling. Science. 2009;324:218-223.
Not in our library10.1126/science.1168978
- 33.
Iwasaki S, Floor SN, Ingolia NT. Rocaglates convert DEAD-box protein eIF4A into a sequence-selective translational repressor. Nature. 2016;534:558-561.
Not in our library10.1038/nature17978
- 34.
Jambhekar A, Derisi JL. Cis-acting determinants of asymmetric, cytoplasmic RNA transport. RNA. 2007;13:625-642.
Not in our library10.1261/rna.262607
- 35.
Jambor H, Mueller S, Bullock SL, Ephrussi A. A stem-loop structure directs Oskar mRNA to microtubule minus ends. RNA. 2014;20:429-439.
Not in our library10.1261/rna.041566.113
- 36.
Kazdoba TM, Leach PT, Silverman JL, Crawley JN. Modeling fragile X syndrome in the Fmr1 knockout mouse. Intractable & Rare Diseases Research. 2014;3:118-133.
Not in our library10.5582/irdr.2014.01024
- 37.
Khandelia P, Yap K, Makeyev EV. Streamlined platform for short hairpin RNA interference and transgenesis in cultured mammalian cells. PNAS. 2011;108:12799-12804.
Not in our library10.1073/pnas.1103532108
- 38.
Kim-Ha J, Webster PJ, Smith JL, Macdonald PM. Multiple RNA regulatory elements mediate distinct steps in localization of oskar mRNA. Development. 1993;119:169-178.
Not in our library10.1242/dev.119.1.169
- 39.
Kislauskis EH, Zhu X, Singer RH. Sequences responsible for intracellular localization of beta-actin messenger RNA also affect cell phenotype. The Journal of Cell Biology. 1994;127:441-451.
Not in our library10.1083/jcb.127.2.441
- 40.
Laggerbauer B, Ostareck D, Keidel EM, Ostareck-Lederer A, Fischer U. Evidence that fragile X mental retardation protein is a negative regulator of translation. Human Molecular Genetics. 2001;10:329-338.
Not in our library10.1093/hmg/10.4.329
- 41.
Lambert N, Robertson A, Jangi M, McGeary S, Sharp PA, Burge CB. RNA Bind-n-Seq: quantitative assessment of the sequence and structural binding specificity of RNA binding proteins. Molecular Cell. 2014;54:887-900.
Not in our library10.1016/j.molcel.2014.04.016
- 42.
Lécuyer E, Yoshida H, Parthasarathy N, Alm C, Babak T, Cerovina T, Hughes TR, Tomancak P, Krause HM. Global analysis of mRNA localization reveals a prominent role in organizing cellular architecture and function. Cell. 2007;131:174-187.
Not in our library10.1016/j.cell.2007.08.003
- 43.
- 44.
Long RM. Mating type switching in yeast controlled by asymmetric localization of ASH1 mRNA. Science. 1997;277:383-387.
Not in our library10.1126/science.277.5324.383
- 45.
- 46.
- 47.
Marín A, Gallardo M, Kato Y, Shirahige K, Gutiérrez G, Ohta K, Aguilera A. Relationship between G+C content, ORF-length and mRNA concentration in Saccharomyces cerevisiae. Yeast. 2003;20:703-711.
Not in our library10.1002/yea.992
- 48.
Maurin T, Lebrigand K, Castagnola S, Paquet A, Jarjat M, Popa A, Grossi M, Rage F, Bardoni B. HITS-CLIP in various brain Areas reveals new targets and new modalities of RNA binding by fragile X mental retardation protein. Nucleic Acids Research. 2018;46:6344-6355.
Not in our library10.1093/nar/gky267
- 49.
Mazroui R, Huot ME, Tremblay S, Boilard N, Labelle Y, Khandjian EW. Fragile X mental retardation protein determinants required for its association with polyribosomal mRNPs. Human Molecular Genetics. 2003;12:3087-3096.
Not in our library10.1093/hmg/ddg335
- 50.
Menon L, Mader SA, Mihailescu MR. Fragile X mental retardation protein interactions with the microtubule associated protein 1B RNA. RNA. 2008;14:1644-1655.
Not in our library10.1261/rna.1100708
- 51.
Minis A, Dahary D, Manor O, Leshkowitz D, Pilpel Y, Yaron A. Subcellular transcriptomics-Dissection of the mRNA composition in the axonal compartment of sensory neurons. Developmental Neurobiology. 2014;74:365-381.
Not in our library10.1002/dneu.22140
- 52.
Moccia R, Chen D, Lyles V, Kapuya E, Kalachikov S, Spahn CM, Frank J, Kandel ER, Barad M, Martin KC. An unbiased cDNA library prepared from isolated Aplysia sensory neuron processes is enriched for cytoskeletal and translational mRNAs. The Journal of Neuroscience. 2003;23:9409-9417.
Not in our library10.1523/jneurosci.23-28-09409.2003
- 53.
Moor AE, Golan M, Massasa EE, Lemze D, Weizman T, Shenhav R, Baydatch S, Mizrahi O, Winkler R, Golani O, Stern-Ginossar N, Itzkovitz S. Global mRNA polarization regulates translation efficiency in the intestinal epithelium. Science. 2017;357:1299-1303.
Not in our library10.1126/science.aan2399
- 54.
Muddashetty RS, Kelic S, Gross C, Xu M, Bassell GJ. Dysregulated metabotropic glutamate Receptor-Dependent translation of AMPA receptor and postsynaptic Density-95 mRNAs at synapses in a mouse model of fragile X syndrome. Journal of Neuroscience. 2007;27:5338-5348.
Not in our library10.1523/jneurosci.0937-07.2007
- 55.
Mueller F, Senecal A, Tantale K, Marie-Nelly H, Ly N, Collin O, Basyuk E, Bertrand E, Darzacq X, Zimmer C. FISH-quant: automatic counting of transcripts in 3D FISH images. Nature Methods. 2013;10:277-278.
Not in our library10.1038/nmeth.2406
- 56.
Mukherjee N, Corcoran DL, Nusbaum JD, Reid DW, Georgiev S, Hafner M, Ascano M, Tuschl T, Ohler U, Keene JD. Integrative regulatory mapping indicates that the RNA-binding protein HuR couples pre-mRNA processing and mRNA stability. Molecular Cell. 2011;43:327-339.
Not in our library10.1016/j.molcel.2011.06.007
- 57.
Patro R, Duggal G, Love MI, Irizarry RA, Kingsford C. Salmon provides fast and bias-aware quantification of transcript expression. Nature Methods. 2017;14:417-419.
Not in our library10.1038/nmeth.4197
- 58.
Pilaz LJ, Lennox AL, Rouanet JP, Silver DL. Dynamic mRNA transport and local translation in radial glial progenitors of the developing brain. Current Biology. 2016;26:3383-3392.
Not in our library10.1016/j.cub.2016.10.040
- 59.
Qi Y, Wang JK, McMillian M, Chikaraishi DM. Characterization of a CNS cell line, CAD, in which morphological differentiation is initiated by serum deprivation. The Journal of Neuroscience. 1997;17:1217-1225.
Not in our library10.1523/jneurosci.17-04-01217.1997
- 60.
Ramos A, Hollingworth D, Pastore A. G-quartet-dependent recognition between the FMRP RGG box and RNA. RNA. 2003;9:1198-1207.
Not in our library10.1261/rna.5960503
- 61.
Ray D, Kazan H, Cook KB, Weirauch MT, Najafabadi HS, Li X, Gueroussov S, Albu M, Zheng H, Yang A, Na H, Irimia M, Matzat LH, Dale RK, Smith SA, Yarosh CA, Kelly SM, Nabet B, Mecenas D, Li W, Laishram RS, Qiao M, Lipshitz HD, Piano F, Corbett AH, Carstens RP, Frey BJ, Anderson RA, Lynch KW, Penalva LO, Lei EP, Fraser AG, Blencowe BJ, Morris QD, Hughes TR. A compendium of RNA-binding motifs for decoding gene regulation. Nature. 2013;499:172-177.
Not in our library10.1038/nature12311
- 62.
- 63.
Rhodes D, Lipps HJ. G-quadruplexes and their regulatory roles in biology. Nucleic Acids Research. 2015;43:8627-8637.
Not in our library10.1093/nar/gkv862
- 64.
Rogmann JJ. CRAN. 2013.
Not in our library
- 65.
Santoro MR, Bray SM, Warren ST. Molecular mechanisms of fragile X syndrome: a twenty-year perspective. Annual Review of Pathology: Mechanisms of Disease. 2012;7:219-245.
Not in our library10.1146/annurev-pathol-011811-132457
- 66.
Schaeffer C, Bardoni B, Mandel JL, Ehresmann B, Ehresmann C, Moine H. The fragile X mental retardation protein binds specifically to its mRNA via a purine quartet motif. The EMBO Journal. 2001;20:4803-4813.
Not in our library10.1093/emboj/20.17.4803
- 67.
Schrier M, Severijnen LA, Reis S, Rife M, van't Padje S, van Cappellen G, Oostra BA, Willemsen R. Transport kinetics of FMRP containing the I304N mutation of severe fragile X syndrome in neurites of living rat PC12 cells. Experimental Neurology. 2004;189:343-353.
Not in our library10.1016/j.expneurol.2004.05.039
- 68.
- 69.
St Johnston D, Beuchle D, Nüsslein-Volhard C. Staufen, a gene required to localize maternal RNAs in the Drosophila egg. Cell. 1991;66:51-63.
Not in our library10.1016/0092-8674(91)90138-o
- 70.
Subramanian M, Rage F, Tabet R, Flatter E, Mandel JL, Moine H. G-quadruplex RNA structure as a signal for neurite mRNA targeting. EMBO Reports. 2011;12:697-704.
Not in our library10.1038/embor.2011.76
- 71.
Suhl JA, Chopra P, Anderson BR, Bassell GJ, Warren ST. Analysis of FMRP mRNA target datasets reveals highly associated mRNAs mediated by G-quadruplex structures formed via clustered WGGA sequences. Human Molecular Genetics. 2014;23:5479-5491.
Not in our library10.1093/hmg/ddu272
- 72.
Taliaferro JM, Vidaki M, Oliveira R, Olson S, Zhan L, Saxena T, Wang ET, Graveley BR, Gertler FB, Swanson MS, Burge CB. Distal alternative last exons localize mRNAs to neural projections. Molecular Cell. 2016a;61:821-833.
Not in our library10.1016/j.molcel.2016.01.020
- 73.
Taliaferro JM, Lambert NJ, Sudmant PH, Dominguez D, Merkin JJ, Alexis MS, Bazile C, Burge CB. RNA sequence context effects measured in Vitro Predict In Vivo Protein Binding and Regulation. Molecular Cell. 2016b;64:294-306.
Not in our library10.1016/j.molcel.2016.08.035
- 74.
Taylor AM, Berchtold NC, Perreau VM, Tu CH, Li Jeon N, Cotman CW. Axonal mRNA in uninjured and regenerating cortical mammalian axons. Journal of Neuroscience. 2009;29:4697-4707.
Not in our library10.1523/jneurosci.6130-08.2009
- 75.
Tsanov N, Samacoits A, Chouaib R, Traboulsi AM, Gostan T, Weber C, Zimmer C, Zibara K, Walter T, Peter M, Bertrand E, Mueller F. smiFISH and FISH-quant - a flexible single RNA detection approach with super-resolution capability. Nucleic Acids Research. 2016;44:e165.
Not in our library10.1093/nar/gkw784
- 76.
Tushev G, Glock C, Heumüller M, Biever A, Jovanovic M, Schuman EM. Alternative 3' UTRs modify the localization, regulatory potential, stability, and plasticity of mRNAs in neuronal compartments. Neuron. 2018;98:495-511.
Not in our library10.1016/j.neuron.2018.03.030
- 77.
Vasilyev N, Polonskaia A, Darnell JC, Darnell RB, Patel DJ, Serganov A. Crystal structure reveals specific recognition of a G-quadruplex RNA by a β-turn in the RGG motif of FMRP. PNAS. 2015;112:E5391-E5400.
Not in our library10.1073/pnas.1515737112
- 78.
Wang H, Dictenberg JB, Ku L, Li W, Bassell GJ, Feng Y. Dynamic association of the fragile X mental retardation protein as a messenger ribonucleoprotein between microtubules and polyribosomes. Molecular Biology of the Cell. 2008;19:105-114.
Not in our library10.1091/mbc.e07-06-0583
- 79.
Wang ET, Cody NA, Jog S, Biancolella M, Wang TT, Treacy DJ, Luo S, Schroth GP, Housman DE, Reddy S, Lécuyer E, Burge CB. Transcriptome-wide regulation of pre-mRNA splicing and mRNA localization by muscleblind proteins. Cell. 2012;150:710-724.
Not in our library10.1016/j.cell.2012.06.041
- 80.
Wang ET, Taliaferro JM, Lee JA, Sudhakaran IP, Rossoll W, Gross C, Moss KR, Bassell GJ. Dysregulation of mRNA localization and translation in genetic disease. The Journal of Neuroscience. 2016;36:11418-11426.
Not in our library10.1523/jneurosci.2352-16.2016
- 81.
- 82.
Yoon JH, Gorospe M. Cross-Linking immunoprecipitation and qPCR (CLIP-qPCR) Analysis to map interactions between long noncoding RNAs and RNA-Binding proteins. Methods in Molecular Biology. 2016;1402:11-17.
Not in our library10.1007/978-1-4939-3378-5_2
- 83.
Zalfa F, Eleuteri B, Dickson KS, Mercaldo V, De Rubeis S, di Penta A, Tabolacci E, Chiurazzi P, Neri G, Grant SG, Bagni C. A new function for the fragile X mental retardation protein in regulation of PSD-95 mRNA stability. Nature Neuroscience. 2007;10:578-587.
Not in our library10.1038/nn1893
- 84.
Zang JB, Nosyreva ED, Spencer CM, Volk LJ, Musunuru K, Zhong R, Stone EF, Yuva-Paylor LA, Huber KM, Paylor R, Darnell JC, Darnell RB. A mouse model of the human fragile X syndrome I304N mutation. PLOS Genetics. 2009;5:e1000758.
Not in our library10.1371/journal.pgen.1000758
- 85.
- 86.
Zhang HL, Eom T, Oleynikov Y, Shenoy SM, Liebelt DA, Dictenberg JB, Singer RH, Bassell GJ. Neurotrophin-induced transport of a beta-actin mRNP complex increases beta-actin levels and stimulates growth cone motility. Neuron. 2001;31:261-275.
Not in our library10.1016/s0896-6273(01)00357-9
- 87.
Zhang Y, Gaetano CM, Williams KR, Bassell GJ, Mihailescu MR. FMRP interacts with G-quadruplex structures in the 3'-UTR of its dendritic target Shank1 mRNA. RNA Biology. 2014;11:1364-1374.
Not in our library10.1080/15476286.2014.996464
Cited by papers we hold 3
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.